Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)
109.86 x 1 N/A x N/A
Post-market by (Cboe BZX)
277.79 +5.53 (+2.03%) 04/16/25 [NYSE]
109.86 x 1 N/A x N/A
Post-market 285.00 +7.21 (+2.60%) 19:00 ET
Quote Overview for Wed, Apr 16th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
271.13
Day High
277.79
Open 272.01
Previous Close 272.26 272.26
Volume 433,500 433,500
Avg Vol 452,830 452,830
Stochastic %K 79.26% 79.26%
Weighted Alpha +42.83 +42.83
5-Day Change +2.33 (+0.85%) +2.33 (+0.85%)
52-Week Range 148.00 - 310.00 148.00 - 310.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,532,104
  • Shares Outstanding, K 38,684
  • Annual Sales, $ 1,195 M
  • Annual Income, $ 14,010 K
  • EBIT $ 9 M
  • EBITDA $ 33 M
  • 60-Month Beta 0.56
  • Price/Sales 8.75
  • Price/Cash Flow 93.63
  • Price/Book 9.01

Options Overview Details

View History
  • Implied Volatility 54.04% ( -0.44%)
  • Historical Volatility 42.36%
  • IV Percentile 91%
  • IV Rank 62.15%
  • IV High 66.83% on 07/30/24
  • IV Low 33.05% on 02/20/25
  • Put/Call Vol Ratio 0.08
  • Today's Volume 84
  • Volume Avg (30-Day) 76
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 4,610
  • Open Int (30-Day) 5,874

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.66
  • Number of Estimates 11
  • High Estimate 0.73
  • Low Estimate 0.52
  • Prior Year 0.41
  • Growth Rate Est. (year over year) +60.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
246.45 +12.72%
on 04/07/25
Period Open: 272.62
288.57 -3.74%
on 03/25/25
+5.17 (+1.90%)
since 03/14/25
3-Month
246.45 +12.72%
on 04/07/25
Period Open: 262.31
310.00 -10.39%
on 02/19/25
+15.48 (+5.90%)
since 01/16/25
52-Week
148.00 +87.70%
on 07/31/24
Period Open: 210.05
310.00 -10.39%
on 02/19/25
+67.74 (+32.25%)
since 04/16/24

Most Recent Stories

More News
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

MMSI : 90.57 (-1.51%)
PEN : 277.79 (+2.03%)
ICUI : 139.14 (-0.36%)
AORT : 23.08 (+0.26%)
3 Reasons PEN is Risky and 1 Stock to Buy Instead

3 Reasons PEN is Risky and 1 Stock to Buy Instead

MSFT : 371.61 (-3.66%)
PEN : 277.79 (+2.03%)
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

MMSI : 90.57 (-1.51%)
PEN : 277.79 (+2.03%)
ICUI : 139.14 (-0.36%)
AORT : 23.08 (+0.26%)
3 Mid-Cap Stocks in Hot Water

3 Mid-Cap Stocks in Hot Water

PEN : 277.79 (+2.03%)
NVR : 7,045.01 (-2.22%)
CHD : 102.96 (-2.01%)
Merit Medical Systems (MMSI) Q4 Earnings Report Preview: What To Look For

Merit Medical Systems (MMSI) Q4 Earnings Report Preview: What To Look For

MMSI : 90.57 (-1.51%)
PEN : 277.79 (+2.03%)
ISRG : 481.34 (-1.42%)
Artivion (AORT) Q4 Earnings: What To Expect

Artivion (AORT) Q4 Earnings: What To Expect

PEN : 277.79 (+2.03%)
ISRG : 481.34 (-1.42%)
AORT : 23.08 (+0.26%)
Why Penumbra (PEN) Stock Is Trading Up Today

Why Penumbra (PEN) Stock Is Trading Up Today

PEN : 277.79 (+2.03%)
Penumbra: Q4 Earnings Snapshot

Penumbra: Q4 Earnings Snapshot

PEN : 277.79 (+2.03%)
Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates

Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates

PEN : 277.79 (+2.03%)
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings

Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings

PEN : 277.79 (+2.03%)
ISRG : 481.34 (-1.42%)
QDEL : 25.27 (-4.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 288.25
2nd Resistance Point 283.50
1st Resistance Point 280.64
Last Price 277.79
1st Support Level 273.03
2nd Support Level 268.28
3rd Support Level 265.42

See More

52-Week High 310.00
Last Price 277.79
Fibonacci 61.8% 248.12
Fibonacci 50% 229.00
Fibonacci 38.2% 209.88
52-Week Low 148.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro